Vivo Infusion, a nationally recognized provider of accessible and
affordable ambulatory infusion services, announced today it has
acquired the Neurology Institute of San Antonio (“NISA”) and
Vista Infusions (“Vista”) (collectively “the Company”), an
industry leader in ambulatory infusion services and a leading
neurological center of excellence. With this acquisition, Vivo
Infusion will manage nearly 90 ambulatory infusion centers across
15 states. Financial terms of the transaction were not disclosed.
Founded in 2003, the Company provides outstanding patient care to
the local community and has grown in the greater San Antonio
market through de novo center openings. The Company is a leader
as the infusion provider of choice for patients suffering from
multiple sclerosis and other neurological conditions. Following
the transaction, Vivo will have 20 locations across Texas
including infusion centers in Dallas, Houston, Longview, Tyler
and San Antonio.
“We are thrilled to continue to build on the reputation of NISA
and Vista Infusions and welcome them into the Vivo family,” said
Steve Rodgers, Chief Executive Officer of Vivo Infusion. “NISA
and Vista continue Vivo’s emphasis as an infusion provider of
choice for neurological and autoimmune diseases. We believe that
by partnering with leading physician practices like that of Drs.
Gazda and Neiman, we can advance the quality of care for patients
while improving value. We are delighted to join forces with Drs.
Gazda, Neiman, and the entire NISA and Vista teams.”
“I am excited to join the Vivo platform. We look forward to
bringing Vivo and Vista together to deliver an industry-leading
patient and provider experience,” said Dr. Suzanne Gazda. Dr.
Gazda and Dr. Braden Neiman will continue practicing as
neurologists with Vivo’s assistance in growth initiatives.
Fifth Third Securities served as the exclusive financial advisor
to NISA and Vista Infusions for this transaction.
About Vivo Infusion
Vivo Infusion is a leading provider of accessible, affordable,
community-based infusion and injection care for patients
suffering from compromised immune systems, cancer-related
diagnoses, and other medical conditions. Vivo Infusion provides
compassionate, expert care administered in safe, accessible
facilities using efficient and cost-effective, patient-focused
best practices. Vivo currently serves communities in fifteen
states, with plans to expand into additional markets. For more
information, visit: https://vivoinfusion.com/.
About NISA and Vista Infusions
Neurology Institute of San Antonio and Vista Infusions is a
leading provider of ambulatory infusion services and a
neurological center of excellence providing service to patients
throughout Texas. The Company specializes in long-term treatment
of neurological conditions and has developed a reputation for
high quality patient care, professionalism and management of
complex conditions in an affordable and accessible setting. For
more information, please visit: https://www.vistainfusions.com/.
The M&A market for healthcare companies continues to build on STRATEGIC opportunities and a fragmented market. Consolidations along with unprecedented demand are driving scale across the continuum of care. The strategic corporate buyers and private equity investors remain committed to acquiring strong businesses that are well prepared for a transaction. Across the continuum of care, these buyers and investors are looking for well established, profitable businesses and offering prime valuations and options for management.
Do you know the current market value of your business? We do! We are here to help you plan, prepare, explore and succeed in executing your strategic options.
Contact Paragon Ventures for more information.
800-719-1555
